America has been experiencing a fast-spreading, wide-reaching health emergency pandemic of seismic proportions. Residents nationwide are sick and/or quarantined, unable to work, and unable to earn incomes. Many Americans are forced to stay home, and non-essential businesses are barred from operating.

Health insurers are pushing Congress for more government help in the face of Covid-19—including near total premium subsidies for people who lose their jobs and stay on their employer-sponsored insurance—but they’re steering clear of the next step, full government-sponsored coverage.

The small-business loan program that received a new infusion of cash last week reopened with a sputter Monday as the Lakers became the latest high-profile name to return money received under a program designed to boost small, struggling companies during the COVID-19 pandemic.

After hearing for months about serious access issues involving tests that diagnose COVID-19 based on swabs from the nose or throat, Americans are being inundated with reports about promising new tests that look for signs of infection in the blood.

Inova Health System, with campuses in some of the wealthiest suburbs of Washington, D.C., and Truman Medical Centers, a safety-net hospital in downtown Kansas City, Missouri, have little in common. But, today, they are confronting the same financial plague: mass cancellations of nonessential surgeries that are their biggest moneymakers while bracing for an expensive onslaught of coronavirus patients.

During the first week of school closures in San Jose, state Sen. Jim Beall’s office received more than a dozen phone calls from distressed parents and caregivers.